Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial

Jacques Donnez, Hugh S Taylor, Robert N Taylor, Mark Akin, Mark D Akin, Т. Ф Татарчук, Tatyana F Tatarchuk, Krzysztof Wilk, Jean‐Pierre Gotteland, Jean-Pierre Gotteland, Veronique Lecomte, V. Lecomte, Elke Bestel
Fertility and sterility · 2020 · vol. 114(1) , pp. 44–55 · doi:10.1016/j.fertnstert.2020.02.114 · PMID:32505383 · W3033596374
article OA: bronze CC0 ⤵ 70 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This randomized clinical trial evaluated the efficacy and safety of linzagolix, an oral GnRH antagonist, for treating endometriosis-associated pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Carboxylic Acids Carboxylic Acids Carboxylic Acids Chronic Pain Chronic Pain Chronic Pain Endometriosis Endometriosis Endometriosis Hormone Antagonists Hormone Antagonists Hormone Antagonists Pelvic Pain Pelvic Pain Pelvic Pain Pyrimidines Pyrimidines Pyrimidines Uterine Diseases Uterine Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:59.141895+00:00
License: CC0 · commercial use OK